Design of Nucleoside Analogs as Potential Antiviral Agents

  • Roland K. Robins
  • Ganapathi R. Revankar
Part of the NATO ASI Series book series (NSSA, volume 143)


Viruses are composed of either RNA or DNA, encased in protein shells and often further wrapped in lipid-containing envelopes. Viruses multiply only within living cells, commandeering the host cell to synthesize viral proteins and viral nucleic acids followed by final assembly into new virion particles. Viral infection may vary in severity from mild and transitory infections to illnesses that terminate in death. Persistent viral infection, which for years may not be accompanied by symptoms, can eventually cause chronic degenerative diseases with fatal outcome. It is known that viruses cause certain cancers in animals and man. Successful treatment of viral diseases with antiviral agents requires interruption of virus multiplication by specific inhibition of viral enzymes.


Human Immunodeficiency Virus Thymidine Kinase Newcastle Disease Virus Nucleoside Analog Antiviral Agent 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    B. Öberg and N.G. Johansson, J. Antimicrob. Chemother., 14, Suppl. A, 5 (1984).Google Scholar
  2. 2.
    J. Hochsladt, Crit. Rev. Biochem. 2, 259 (1974).Google Scholar
  3. 3.
    R.D. Berlin and J.M. Oliver, Int. Rev. Cytol., 42, 287 (1975).PubMedCrossRefGoogle Scholar
  4. 4.
    W.H. Prusoff, Biochim. Biophys. Acta, 32, 295 (1959).PubMedCrossRefGoogle Scholar
  5. 5.
    E.C. Herrmann, Jr., Proc. Soc. Exp. Biol. Med., 107, 142 (1961).Google Scholar
  6. 6.
    H.E. Kaufman and E.D. Maloney, Arch. Ophthalmol., 68, 396 (1962).PubMedCrossRefGoogle Scholar
  7. 7.
    H.E. Kaufman, Proc. Soc. Exp. Biol. Med., 109, 251 (1962).Google Scholar
  8. 8.
    A.S. Jones, G. Verhelst and R.T. Walker, Tetrahedron Lett., 4415 (1979).Google Scholar
  9. 9.
    E. De Clercq, J. Descamps, P. De Somer, P.J. Barr, A.S. Jones and R.T. Walker, Proc. Natl. Acad. Sci., USA, 76, 2947 (1979).PubMedCrossRefGoogle Scholar
  10. 10.
    E. De Clercq and R.T. Walker, Pharmacol. Ther. 26, 1 (1984).PubMedCrossRefGoogle Scholar
  11. 11.
    J. Wildiers and E. De Clercq, Eur. J. Cancer Clin. Oncol., 20, 471 (1984).PubMedCrossRefGoogle Scholar
  12. 12.
    S. Olofsson, M. Lundström and R. Datema, Virology, 147, 201 (1985).PubMedCrossRefGoogle Scholar
  13. 13.
    K.A. Watanabe, U. Reichman, K. Hirota, C. Lopez and J.J. Fox, J. Med. Chem., 22, 21 (1979).PubMedCrossRefGoogle Scholar
  14. 14.
    R.F. Schnazi, J. Peters, M. K. Sokol and A.J. Nahmias, Antimicrob. Agents Chemother., 24, 95 (1983).Google Scholar
  15. 15.
    A. Feinberg, B. Leyland-Jones, M.P. Fanucchi, C. Hancock, J.J. Fox, K.A. Watanabe, P.M. Vidal, L. Williams, C.W. Young and F.S. Philips, Antimicrob. Agents Chemother., 27, 733 (1985).PubMedGoogle Scholar
  16. 16.
    B. Leyland-Jones, H. Donnelly, S. Groshen, P. Myskowski, A. L. Donner, M. Fanucchi, J.J. Fox and the Memorial Sloan-Kettering Antiviral Working Group, J. Infect. Dis., 154, 430 (1986).PubMedCrossRefGoogle Scholar
  17. 17.
    C.W. Young, R. Schneider, B. Leyland-Jones, D. Armstrong, CTC Tan, C. Lopez, K.A. Watanabe, J.J. Fox, F.S. Phillips, Cancer Res., 43, 5006 (1983).Google Scholar
  18. 18.
    W. Bergman and R.J. Feeney, J. Am. Chem. Soc., 72, 2809 (1950).CrossRefGoogle Scholar
  19. 18a.
    W. Bergman and R.J. Feeney J. Org. Chem., 16, 981 (1951).CrossRefGoogle Scholar
  20. 19.
    J.J. Fox, N. Yung and A. Bendich, J. Am. Chem. Soc., 79, 2775 (1957).CrossRefGoogle Scholar
  21. 20.
    G.E. Underwood, C.A. Wisner and S.D. Weed, Arch. Ophthalmol., 72, 505 (1964).PubMedCrossRefGoogle Scholar
  22. 21.
    G.A. Gentry and J.F. Aswell, Virology, 65, 294 (1975).PubMedCrossRefGoogle Scholar
  23. 22.
    O. Nakayama, H. Machida and M. Saneyoshi, J. Carbohydrates Nucleosides Nucleotides, 6, 295 (1979).Google Scholar
  24. 23.
    H. Machida, S. Sakata, S. Kuninaka, H. Yoshino, O. Nakayama and M. Saneyoshi, Antimicrob. Agents Chemother., 16, 158 (1979).PubMedGoogle Scholar
  25. 24.
    W.W. Lee, A. Benetz, L. Goodman and B.R. Baker, J. Am. Chem. Soc., 82, 2648 (1960).CrossRefGoogle Scholar
  26. 25.
    F.A. Miller, G.J. Dixon, J. Ehrlich, B.J. Sloan and I.W. McLean, Jr., Antimicrob. Agents Chemother., 136 (1968).Google Scholar
  27. 26.
    M. P. de Garilhe and J. de Rudder, Compt. Rend. Acad. Sci., 259, 2725 (1964).Google Scholar
  28. 27.
    R.W. Sidwell, G.J. Dixon, F.M. Schabel Jr. and D.H. Kamp, Antimicrob. Agents Chemother., 148 (1968). See also:Google Scholar
  29. 27a.
    F.M. Schabel, Jr., Chemotherapy, 13, 321 (1968).PubMedCrossRefGoogle Scholar
  30. 28.
    G.L. Vilde, F. Bricaire, A. Huchon and F. Brun-Vezinet, J. Med. Virol., 12, 149 (1983).PubMedCrossRefGoogle Scholar
  31. 29.
    T.W. North and S.S. Cohen, Pharmacol. Ther., 4, 81 (1979).PubMedCrossRefGoogle Scholar
  32. 30.
    C. Shipman, Jr., U.S. Smith, R.H. Carlson and J.C. Drach, Antimicrob. Agents Chemother., 9, 120 (1976).PubMedGoogle Scholar
  33. 31.
    W.E.G. Muller, R.K. Zahn, K. Bittlingmaier and D. Falke, Ann. N. Y. Acad. Sci., 284, 34 (1977).PubMedCrossRefGoogle Scholar
  34. 32.
    W.E.G. Muller, R.K. Zahn, R. Beyer and D. Falke, Virology, 76, 787 (1977).PubMedCrossRefGoogle Scholar
  35. 33.
    J.C. Pelling, J.C. Drach and C. Shipman Jr., Virology, 104, 323 (1981).CrossRefGoogle Scholar
  36. 34.
    R. Vince and S. Daluge, J. Med. Chem., 20, 612 (1977).PubMedCrossRefGoogle Scholar
  37. 35.
    R. Vince, S. Daluge, H. Lee, W.M. Shannon, G. Arnett, T. Schafer, T.L. Nagabhushan, P. Riechert and H. Tsai, Science, 221, 1405 (1983).PubMedCrossRefGoogle Scholar
  38. 36.
    A. Holý, Chemica Scripta, 26, 83 (1986).Google Scholar
  39. 37.
    E. De Clercq, A. Holy, I. Rosenberg, T. Sakuma, J. Balzarini and P.C. Maudgal, Nature, 323, 464 (1986).PubMedCrossRefGoogle Scholar
  40. 38.
    M.J. Robins, Y. Fouron and W.H. Muhs, Can. J. Chem., 55, 1260 (1977).CrossRefGoogle Scholar
  41. 39.
    E. De Clercq, J. Balzarini, D. Madej, F. Hansske and M.J. Robins, J. Med. Chem., 30, 481 (1987).PubMedCrossRefGoogle Scholar
  42. 40.
    E. De Clercq and M.J. Robins, Antimicrob. Agents Chemother., 30, 719 (1986).PubMedGoogle Scholar
  43. 41.
    R.I. Glazer and A.L. Peale, Biochem. Biophys. Res. Commun., 81, 521 (1978).PubMedCrossRefGoogle Scholar
  44. 41a.
    R. I. Glazer and A. L. Peale, Cancer Lett., 6, 193 (1979).PubMedCrossRefGoogle Scholar
  45. 42.
    G.B. Elion, P.A. Furman, J.A. Fyle, P. de Miranda, L. Beauchamp and H.J. Schaeffer, Proc. Natl. Acad. Sci., USA, 74, 5716 (1977).PubMedCrossRefGoogle Scholar
  46. 43.
    H.J. Schaeffer, L. Beauchamp, P. de Miranda, G.B. Elion, D.J. Bauer and P. Collins, Nature, 272, 583 (1978).PubMedCrossRefGoogle Scholar
  47. 44.
    H.J. Schaeffer, Am. J. Med., 73 (#1A), 4 (1982).PubMedCrossRefGoogle Scholar
  48. 45.
    A. P. Feddian, D. Brigden, J. M. Yeo and E. A. Hickmott, Antiviral Res., 4, 99 (1984CrossRefGoogle Scholar
  49. 45a.
    R. Dolin, Science, 227, 1296 (1985);PubMedCrossRefGoogle Scholar
  50. 45b.
    L. Corey and P. G. Spear, New Eng. J. Med., 314, 749 (1986);PubMedCrossRefGoogle Scholar
  51. 45c.
    B. Bean, Postgraduate Med., 80, 113 (1986).Google Scholar
  52. 46.
    D. Gold and L. Corey, Antimicrob. Agents Chemother., 31, 361 (1987).PubMedGoogle Scholar
  53. 47.
    R. J. Whitley, C. A. Alford, M. S. Hirsch, R.T. Schooley, J. P. Luby, F.Y. Aoki, D. Hanley, A. J. Nahmias and S-J. Soong, N. Eng. J. Med., 314, 144 (1986).CrossRefGoogle Scholar
  54. 48.
    J. Andersson, S. Britton, I. Ernberg, U. Andersson, W. Henle, B. Sköldenberg and A. Tisell, J. Infect. Dis., 153, 283 (1986).PubMedCrossRefGoogle Scholar
  55. 49.
    G.B. Elion, Am. J. Med., 73, 7 (1982).PubMedCrossRefGoogle Scholar
  56. 50.
    J.A. Fyfe, P.M. Keller, P.A. Furman, R.L. Miller and G.B Elion, J. Biol. Chem., 253, 8721 (1978).PubMedGoogle Scholar
  57. 51.
    P.V. McGuirt, J.E. Shaw, G.B. Elion and P.A. Furman, Antimicrob. Agents Chemother., 25, 507 (1984).PubMedGoogle Scholar
  58. 52.
    A. Larsson, A. Sundquist and A.M. Parnrud, Mol. Pharmacol., 29, 614 (1986).PubMedGoogle Scholar
  59. 53.
    J.C. Martin, C.A. Dvorak, D.F. Smee, T.R. Matthews and J.P.H. Verheyden, J. Med. Chem., 26, 759 (1983).PubMedCrossRefGoogle Scholar
  60. 54.
    D.F. Smee, J.C. Martin, J.P. Verheyden and T.R. Matthews, Antimicrob. Agents Chemother., 23, 676 (1983).PubMedGoogle Scholar
  61. 55.
    A.K. Field, M.E. Davies, C. DeWitt, H.C. Perry, R. Liou, J. Germerhausen, J.D. Karkas, W.T. Ashton, D.B.R. Johnston and R.L. Tolman, Proc. Natl. Acad. Sci., USA, 80, 4139 (1983).PubMedCrossRefGoogle Scholar
  62. 56.
    K.K. Ogilvie, U.O. Cherujan, B.K. Radatus, K.O. Smith, K.S. Galloway and W.L. Kennel, Can. J. Chem., 60, 3005 (1982).CrossRefGoogle Scholar
  63. 56a.
    K. O. Smith, K. S. Galloway, K. K. Ogilvie and U. O. Cherujan, Antimicrcb. Agents Chemother., 27, 1026 (1982).Google Scholar
  64. 57.
    M.H. St. Clair, W.H. Miller, R.L. Miller, C.U. Lambe and P.A. furman, Antimicrob. Agents Chemother., 25, 191 (1984).Google Scholar
  65. 58.
    K.B. Frank, J.F. Chiou and Y.C. Cheng, J. Biol. Chem., 259, 1556 (1984).Google Scholar
  66. 59.
    R.L. Tolman, A.K. Field, J.D. Karkas, A.F. Wagner, J. Germershausen, C. Crumpacker and E.M. Scolnick, Biochem. Biophys. Res. Commun., 128, 1329 (1985).PubMedCrossRefGoogle Scholar
  67. 60.
    J. Germershausen, R. Bostedor, R. Liou, A.K. Field, A.F. Wagner, M. MacCoss, R.L. Tolman and J.D. Karkas, Antimicrob. Agents Chemother., 29, 1025 (1986).PubMedGoogle Scholar
  68. 61.
    J.D. Karkas, J. Germershausen, R.L. Tolman, M. MacCoss, A.F. Wagner, R. Liou and R. Bostedor, Biochem. Biophys. Acta, 911, 127 (1987).PubMedCrossRefGoogle Scholar
  69. 62.
    M. MacCoss, R.L. Tolman, W.T. Ashton, A.F. Wagner, J. Hannah, A.K. Field, J.D. Karkas and J.T. Germershausen, Chemica Scripta, 26, 113 (1986).Google Scholar
  70. 63.
    M.E.M. Davies, J.V. Bondi, L. Grabowski, T.L. Schofield and A.K. Field, Antiviral Res., 7, 119 (1987).PubMedCrossRefGoogle Scholar
  71. 64.
    A.K. Field, M.E.M. Davies, C.M. DeWitt, H.C. Perry, T.L. Schofield, J.D. Karkas, J. Germershausen, A.F. Wagner, C.L. Cantone, M. MacCoss and R.L. Tolman, Antiviral Res., 6, 329 (1986).PubMedCrossRefGoogle Scholar
  72. 65.
    C.M. Vander Horst, J.C Lin, N. Raab-Traub, M.C Smith and J.S. Pagano, J. Virol., 61, 607 (1987).PubMedGoogle Scholar
  73. 66.
    J.C Lin, D.J. Nelson, C.U. Lambe and E.I. Choi, J. Virol., 60, 569 (1986).PubMedGoogle Scholar
  74. 67.
    C.K.Y. Fong, S.D. Cohen, S. McCormick and C.D. Hsiung, Antiviral Res., 7, 11 (1987).PubMedCrossRefGoogle Scholar
  75. 68.
    O.L. Laskin, C.M. Stahl-Bayliss, C.M. Kaiman and L.R. Rosecan, J. Infect. Dis., 155, 323 (1987).PubMedCrossRefGoogle Scholar
  76. 69.
    D. Felsenstein, D. J. D’Amico, M.S. Hirsch, D.A. Neumeyer, D. M. Cederberg, P. de Miranda and R.T. Schooley, Ann. Intern. Med., 103, 377 (1985).PubMedGoogle Scholar
  77. 70.
    D.H. Shepp, P.S. Dandliker, P. de Miranda, T.C Burnette, D.M. Cederberg, L.E. Kirk and J.D. Meyers, Ann. Intern. Med., 103, 368 (1985).PubMedGoogle Scholar
  78. 71.
    E.C Reed, P.S. Dandliker and J.D. Meyers, Ann. Intern. Med., 105, 214 (1986).PubMedGoogle Scholar
  79. 72.
    A. Larsson, B. Oberg, S. Alenius, C.E. Hagberg, N.G. Johansson, B. Lindborg and G. Stening, Antimicrob. Agents Chemother., 23, 664 (1983). PubMedGoogle Scholar
  80. 73.
    B. Lundgren, A.C. Ericson, M. Berg and R. Datema, Antimicrob. Agents Chemother., 29, 294 (1986).PubMedGoogle Scholar
  81. 74.
    K. Stenberg, A. Larsson and R. Datema, J. Biol. Chem., 261, 2134 (1986).PubMedGoogle Scholar
  82. 75.
    A. Larsson, K. Stenberg, A-C Ericson, U. Haglund, W-A. Yisak, N.G. Johansson, B. Öberg and R. Datema, Antimicrob. Agents Chemother., 30, 598 (1986).PubMedGoogle Scholar
  83. 76.
    M. Legraverend, R-M.N. Ngongo-Tekam, E. Bisagni and A. Zerial, J. Med. Chem., 28, 1477 (1985).PubMedCrossRefGoogle Scholar
  84. 77.
    A. Zerial, M. Zerial, M. Legraverend and E. Bisagni, Ann. Inst. Pasteur/Virol., 137E, 317 (1986).CrossRefGoogle Scholar
  85. 78.
    R.J. Rousseau, L. B. Townsend and R. K Robins, Biochemistry, 5, 756 (1966).PubMedCrossRefGoogle Scholar
  86. 79.
    A.J. Bodner, G.L. Cantoni and P.K. Chiang, Biochem. Biophys. Res. Commun., 98, 476 (1981).PubMedCrossRefGoogle Scholar
  87. 80.
    J.P. Bader, N.R. Brown, P.K. Chiang and G.L. Cantoni, Virology, 89, 494 (1978).PubMedCrossRefGoogle Scholar
  88. 81.
    C.S.G. Pugh, R.T. Borchardt and H.O. Stone, Biochemistry, 16, 3928 (1977).PubMedCrossRefGoogle Scholar
  89. 82.
    A. Holy, Coll. Czech. Chem. Commun., 40, 187 (1975).Google Scholar
  90. 83.
    E. De Clercq, J. Descamps, P. De Somer and A. Holy, Science, 200, 563 (1978).CrossRefGoogle Scholar
  91. 84.
    I. Sodja and A. Holy, Acta Virol., 24, 317 (1980).PubMedGoogle Scholar
  92. 85.
    J.A. Montgomery, S.J. Clayton, H.J. Thomas, W.M. Shannon, G. Arnett, A.J. Bodner, I-K. Kion, G.L. Cantoni and P.K. Chiang, J. Med. Chem., 25, 626 (1982).PubMedCrossRefGoogle Scholar
  93. 86.
    E. De Clercq and J.A. Montgomery, Antiviral Res., 3, 17 (1983).PubMedCrossRefGoogle Scholar
  94. 87.
    E. De Clercq, D.E. Bergstrom, A. Holý and J.A. Montgomery, Antiviral Res., 4, 119 (1984).PubMedCrossRefGoogle Scholar
  95. 88.
    M. Hayashi, S. Yaginuma, H. Yoshioka and K. Nakatsu, J. Antibiot., 34, 675 (1981).PubMedCrossRefGoogle Scholar
  96. 89.
    M. Arita, K. Adachi, Y. Ito, H. Sawai and M. Ohno, J. Am. Chem. Soc., 105, 4049 (1983).CrossRefGoogle Scholar
  97. 90.
    R.T. Borchardt, B.T. Keller and U. Patel-Thombre, J. Biol. Chem., 259, 4353 (1984).PubMedGoogle Scholar
  98. 91.
    E. De Clercq, Antimicrob. Agents Chemother., 28, 84 (1985).PubMedGoogle Scholar
  99. 92.
    R.I. Glazer and M.C. Knode, J. Biol. Chem., 259, 12964 (1984).PubMedGoogle Scholar
  100. 93.
    R.L. Hamill and M.M. Holhn, J. Antibiotics, 26, 463 (1973). Also see: R. Nagarajan, B.Chao, D.E. Dorman, S.M. Nash, J.L. Occolowitz and A. Schabel, Conf. on Antimicrob. Agents and Chemother., p.50 (1977).CrossRefGoogle Scholar
  101. 94.
    C.S.G. Pugh, R.T. Borchardt and H.O. Stone, J. Biol. Chem., 253, 4075 (1978).PubMedGoogle Scholar
  102. 95.
    R. Nagarajan, U.S. Patent 4,158,056, 13 July 1978.Google Scholar
  103. 96.
    M. Vedel, F. Lawrence, M. Robert-Gero and E. Lederer, Biochem. Biophys. Res. Commun., 85, 371 (1978).PubMedCrossRefGoogle Scholar
  104. 97.
    J.T. Witkowski, R.K. Robins, R.W. Sidwell and L.N. Simon, J. Med. Chem., 15, 1150 (1972).PubMedCrossRefGoogle Scholar
  105. 98.
    R.W. Sidwell, J.H. Huffman, G.P. Khare, L.B. Allen, J.T. Witkowski and R.K. Robins, Science, 177, 705 (1972).PubMedCrossRefGoogle Scholar
  106. 99.
    For a review of the antiviral activity of ribavirin see: R.W. Sidwell, G.R. Revankar and R.K. Robins in Viral Chemotherapy Volume 2, p. 49, International Encyclopedia of Pharmacology and Therapeutics, section 116, Ed. D.Shugar, Pergamon Press, 1985.Google Scholar
  107. 100.
    J.C. Drach, M.A. Thomas, J.W. Barnett, S.H. Smith and C. Shipman, Jr., Science, 212, 549 (1981).CrossRefGoogle Scholar
  108. 101.
    P.G. Canonico in “Antibiotics VI, Modes and Mechanism of Microbial Growth Inhibitors”, p. 161, Springer-Verlag, 1983.CrossRefGoogle Scholar
  109. 102.
    I.W. Hillyard in “Ribavirin A Broad Spectrum Antiviral Agent”, p. 59, Ed. R.A. Smith and W.A. Kirkpatrick, Academic Press, 1980.Google Scholar
  110. 103.
    B. Eriksson, E. Helgstrand, N.G. Johansson, A. Larsson, A. Misiorny, J.O. Noren, L. Philipson, K. Stenberg, G. Stening, S. Stridh and B. Öberg, Antimicrob. Agents Chemother., 11, 946 (1977).PubMedGoogle Scholar
  111. 104.
    T.P. Zimmerman and R.D. Deeprose, Biochem. Pharmacol., 27, 709 (1978).PubMedCrossRefGoogle Scholar
  112. 105.
    D.G. Streeter, J.T. Witkowski, G.P. Khare, R.W. Sidwell, R.J. Bauer, R.K. Robins and L.N. Simon, Proc. Natl. Acad. Sci., USA, 70, 1174 (1973).PubMedCrossRefGoogle Scholar
  113. 106.
    P. Prusiner and M. Sundaralingam, Nature New Biol., 244, 116 (1973).PubMedGoogle Scholar
  114. 107.
    G.L. Linitskaya, A.A. Yotsyna, N.L. Pushkarskaya and G.A. Galegov, Vopr. Med. Khim., 24, 699 (1978).Google Scholar
  115. 108.
    J.S. Oxford, J. Gen. Virol., 28, 409 (1975).PubMedCrossRefGoogle Scholar
  116. 109.
    F. Bussereau and A. Ermine, Ann. Virol., 134E, 487 (1983).Google Scholar
  117. 110.
    C. Scholtissek, Arch. Virol., 50, 349 (1976).PubMedCrossRefGoogle Scholar
  118. 111.
    B.B. Goswami, E. Borek, O.K. Sharma, J. Fujitaki and R.A. Smith, Biochem. Biophys. Res. Commun., 89, 830 (1979).PubMedCrossRefGoogle Scholar
  119. 112.
    B.B. Goswami, O.K. Sharma, E. Borek and R.A. Smith, Current Chemotherapy and Immunotherapy (Proc. 12th Int. Cong, of Chemother., Florence, Italy 1981) Vol. 2, 1075.Google Scholar
  120. 113.
    E. Katz, E. Margalith and B. Winer, J. Gen. Virol., 32, 327 (1976).PubMedCrossRefGoogle Scholar
  121. 114.
    P. Toltzis and A.S. Huang, Antimicrob. Agents Chemother., 29, 1010 (1986).PubMedGoogle Scholar
  122. 115.
    R.K. Robins, G.R. Revankar, P.A. McKernan, B.K. Murray, J.J. Kirsi and J.A. North, Adv. Enzyme Reg., 24, 29 (1986).CrossRefGoogle Scholar
  123. 116.
    P.G. Canonico, M. Kende, B.J. Luscri and J.W. Huggins, J. Antimicrob. Chemother., 14, Suppl. A p. 27 (1984).PubMedGoogle Scholar
  124. 117.
    J.W. Higgins, G.R. Kim, O.M. Brand and K.T. McKee, Jr., J. Infect. Dis., 153, 489 (1986).CrossRefGoogle Scholar
  125. 118.
    J.B. McCormick, I.J. King, P.A. Wegg, C.L. Scribner, R.B. Craven, K.M. Johnson, L.H. Elliott and R. Belmont-Williams, New. Eng. J. Med., 314, 1 (1986).CrossRefGoogle Scholar
  126. 119.
    M.C. Weissenbacher, M.A. Calello, M.S. Merani, J.B. McCormick and M. Rodriguez, J. Med. Virol., 20, 261 (1980).CrossRefGoogle Scholar
  127. 120.
    W.J. Rodriguez, H.W. Kim, C.D. Brandt, R.J. Fink, P.R. Getson, J. Arrobio, T.M. Murphy, V. McCarthy and R.H. Parrott, Pediatr. Infect. Dis., 6, 159 (1987).CrossRefGoogle Scholar
  128. 121.
    P.A. Conrad, J.C. Christenson, J. L. Waner and M. I. Marks, Pediatr. Infect. Dis., 6, 152 (1987).CrossRefGoogle Scholar
  129. 122.
    P.W. Barnes, Chest, 91, 246 (1987).PubMedCrossRefGoogle Scholar
  130. 123.
    P.F. Smee and T.R. Matthews, Antimicrob. Agents Chemother., 30, 117 (1986).PubMedGoogle Scholar
  131. 124.
    A. Matsumori, H. Wang, W.H. Abelmann and C.W. Crumpacker, Circulation, 71, 834 (1985).PubMedCrossRefGoogle Scholar
  132. 125.
    P.C. Srivastava and R.K. Robins, J. Med. Chem., 26, 445 (1983).PubMedCrossRefGoogle Scholar
  133. 126.
    J.J. Kirsi, J.A. North, P.A. McKernan, B. K. Murray, P. J. Canonico, J. W. Huggins, P. C. Srivastava and R. K. Robins, Antimicrob. Agents Chemother., 24, 353 (1983).PubMedGoogle Scholar
  134. 127.
    R.W. Sidwell, J.H. Huffman, E.W. Call, H. Alaghamandan, P.D. Cook and R.K. Robins, Antimicrob. Agents Chemother. 28, 375 (1985).PubMedGoogle Scholar
  135. 128.
    R.W. Sidwell, J.H. Huffman, E.W. Call, H. Alaghamandan, P.P. Cook and R.K. Robins, Antiviral Res., 6, 343 (1986).PubMedCrossRefGoogle Scholar
  136. 129.
    C.T. Liu, M. J. Griffin, P. B. Jahrling and C. J. Peters. Fed. Proc, 44, March 12, 1985, p. 1836, Abst. #8327.Google Scholar
  137. 130.
    J.W. Huggins, R.K. Robins and P.G. Canonico, Antimicrob. Agents Chemother., 26, 476 (1984).PubMedGoogle Scholar
  138. 131.
    J.J. Kirsi, P.A. McKernan, N.J. Burns III, J.A. North, B.K. Murray and R.K. Robins, Antimicrob. Agents Chemother., 26, 466 (1984).PubMedGoogle Scholar
  139. 132.
    For example see: “Confronting AIDS”, a report of the Committee on a National Strategy for AIPS published Oct. 1986 by the National Academy of Sciences and Institute of Medicine, U.S.A.Google Scholar
  140. 133.
    R.K. Robins, Pharmaceutical Research, 1 (1984).Google Scholar
  141. 134.
    P. Smoler, I. Molleneux and P. Baltimore, J. Biol. Chem., 246, 7696 (1971).Google Scholar
  142. 135.
    P. Furmanski, G.J. Bourguignon, C.X. Bolles, J.P. Corombos, M.R. Pas, Cancer Lett., 8, 307 (1980).PubMedCrossRefGoogle Scholar
  143. 136.
    M.J. Robins and R.K. Robins, J. Am. Chem. Soc., 86, 3585 (1964).CrossRefGoogle Scholar
  144. 137.
    M.A. Wagar, M.J. Evans, K.F. Manly, R.G. Hughes and J. A. Huberman, J. Cell. Physiol., 121, 402 (1984).CrossRefGoogle Scholar
  145. 138.
    H. Mitsuya and S. Broder, Proc. Natl. Acad. Sci., USA, 83, 1911 (1986).PubMedCrossRefGoogle Scholar
  146. 139.
    L. Toji and S.S. Cohen, Proc. Natl. Acad. Sci., USA, 63, 871 (1969);PubMedCrossRefGoogle Scholar
  147. 139a.
    L. Toji and S.S. Cohen, J. Bacteriol., 103, 323 (1970).PubMedGoogle Scholar
  148. 140.
    J.P. Horwitz, J. Chua, M. Noel and J. T. Ponatti, J. Org. Chem., 32, 817 (1967).PubMedCrossRefGoogle Scholar
  149. 141.
    P. A. Cooney, M. Palal, H. Mitsuya, J. B. McMahon, M. Nadkarni, J. Balzarini, S. Broder and P. G. Johns, Biochem. Pharmacol., 35, 2065 (1986). (b)PubMedCrossRefGoogle Scholar
  150. 141a.
    M. C Starnes and Y. C Cheng, J. Biol. Chem., 262, 988 (1987).PubMedGoogle Scholar
  151. 142.
    J.P. Horwitz, J. Cha and M. Noel, J. Org. Chem., 29, 2076 (1964).CrossRefGoogle Scholar
  152. 143.
    H. Mitsuya, K.J. Weinhold, P.A. Furman, M.H. St. Clair, S.N. Lehrman, R.C. Gallo, D. Bolognesi, D.W. Barry and S. Broder, Proc. Natl. Acad. Sci., USA, 82, 7096 (1985).PubMedCrossRefGoogle Scholar
  153. 144.
    P.A. Furman, J.A. Fyfe, M.H. St. Clair, K. Weinhold, J.L. Rideout, G.A. Freeman, S.N. Lehrman, D.P. Bolognesi, S. Broder, H. Mitsuya and D.W. Barry, Proc. Natl. Acad. Sci., USA, 83, 8333 (1986).PubMedCrossRefGoogle Scholar
  154. 145.
    R.M. Ruprecht, L.G. O’Brien, L.D. Rossoni and S.N. Lehrman, Nature, 323, 467 (1986).PubMedCrossRefGoogle Scholar
  155. 146.
    R.W. Sidwell, L.B. Allen, J.H. Huffman, J.T. Witkowski and L.N. Simon, Proc. Soc. Exp. Biol. Med., 148, 854 (1975).PubMedGoogle Scholar
  156. 147.
    W.M. Shannon, Ann. N.Y. Acad. Sci., 284, 472 (1977).PubMedCrossRefGoogle Scholar
  157. 148.
    R.W. Sidwell and D.F. Smee, Antiviral Res., 1, 47 (1981).CrossRefGoogle Scholar
  158. 149.
    F.J. Jenkins and Y.C. Chen, Antimicrob. Agents Chemother., 19, 364 (1981).PubMedGoogle Scholar
  159. 150.
    J.B. McCormick, S.W. Mitchell, J.P. Getchell and D. R. Hicks, Lancet, 1367 (Dec. 15, 1984).Google Scholar
  160. 151.
    R.B. Roberts, J. Laurence, D. Scavusso, Y. Kim and H.W. Murray, Clin. Res., 34, 678 (1986).Google Scholar
  161. 152.
    R.B. Roberts, P.N. Heseltine, P.W.A. Mansell, G.M. Dickinson, J.M. Leedom and K.M. Johnson, Clin. Res., 35, 616A (1987).Google Scholar
  162. 153.
    C. Crumpacker, G. Bubley, S. Hussey, L. Schnipper, W. Heagy, R. Finberg, M.F. McLane, J. Allen and M. Essex, Int. Conf. on AIDS, Paris, June 1986, Abst. #84, S14b.Google Scholar
  163. 154.
    H. Mitsuya and S. Broder, Nature, 325, 773 (1987).PubMedCrossRefGoogle Scholar
  164. 155.
    R. Yarchoan and S. Broder, New Eng. J. Med., 316, 557 (1987).PubMedCrossRefGoogle Scholar
  165. 156.
    A.T. Haase, J. Infect. Dis., 153, 441 (1986).PubMedCrossRefGoogle Scholar
  166. 157.
    B.A. Navia, B.D. Jordan and R.W. Price, Ann. Neurol., 17, 517 (1986).CrossRefGoogle Scholar
  167. 158.
    C. Crumpacker, G. Bubley, D. Lucey, S. Hussey and J. Connor, Lancet, 45 (July 5, 1986).Google Scholar
  168. 159.
    J.C. Torre, B. Alarcon, E. Martinez-Salas, L. Carrasco and E. Domingo, J. Virol., 61, 233 (1987).PubMedGoogle Scholar
  169. 160.
    J.R. McCammon, V.W. Riesser, Antimicrob. Agents. Chemother., 15, 356 (1979).PubMedGoogle Scholar
  170. 161.
    J.J. Browne, M.Y. Moss and M.R. Boyd, Antimicrob. Agents Chemother., 23, 503 (1983).PubMedGoogle Scholar
  171. 162.
    C.S. Crumpacker, L.E. Schnipper, S.I. Marlowe, P.N. Kowalsky, B.J. Hershey and M.J. Levin, New. Eng. J. Med., 306, 343 (1982).PubMedCrossRefGoogle Scholar
  172. 163.
    C. McLaren, M.S. Chen, I. Ghazzouli, R. Sarai and W.H. Burns, Antimicrob. Agents. Chemother., 28, 740 (1986).Google Scholar
  173. 164.
    H.J. Field, Brit. Med. Bull., 41, 345 (1985).PubMedGoogle Scholar
  174. 165.
    J.H. Huffman, L.B. Allen, R.W. Sidwell, Ann. N.Y. Acad. Sci., 284, 233 (1977).PubMedCrossRefGoogle Scholar
  175. 166.
    E. De Clercq, R. Bernaerts, D.E. Bergstrom, M.J. Robins, J.A. Montgomery and A. Holy, Antimicrob. Agents Chemother., 29, 482 (1986).PubMedGoogle Scholar
  176. 167.
    P.D. Cook, R.J. Rousseau, A.M. Mian, P. Dea, R.B. Meyer, Jr., and R. K. Robins, J. Am. Chem. Soc., 98, 1492 (1976).PubMedCrossRefGoogle Scholar
  177. 168.
    L.B. Allen, J.H. Huffman, P.D. Cook, R.B. Meyer, Jr., R. K. Robins and R.W. Sidwell, Antimicrob. Agents Chemother., 12, 114 (1977).PubMedGoogle Scholar
  178. 169.
    P. P. Saunders, M. T. Tan, CD. Spindler, R. K. Robins and W. Plunkett, J. Biol. Chem., 261, 6416 (1986) and earlier references.PubMedGoogle Scholar
  179. 170.
    T.M. Page, S.J. Jacobsen, W.L. Nyan, J.H. Mangum and R.K. Robins, Int. J. Biochem., 18, 957 (1986).PubMedCrossRefGoogle Scholar
  180. 171.
    R.O. Pieper, L.R. Barrows and H.G. Mandel, Cancer Res., 46, 4960 (1986).PubMedGoogle Scholar
  181. 172.
    E. De Clercq and P.F. Torrence, J. Carbohydr. Nucleosides Nucleotides, 5, 187 (1978).Google Scholar
  182. 173.
    P.G. Canonico, P.B. Jährling and W.L. Pannier, Antiviral Res., 2, 331 (1983).CrossRefGoogle Scholar
  183. 174.
    C.R. Petrie III, G.R. Revankar, N.K. Dalley, R.D. George, P.A. McKernan, R.L. Hamill and R.K. Robins, J. Med. Chem., 29, 268 (1986).PubMedCrossRefGoogle Scholar
  184. 175.
    W.H. Prusoff, W.R. Mancini, T.S. Lin, J.J. Lee, S.A. Siegel and M.J. Otto, Antiviral Res., 4, 303 (1984).PubMedCrossRefGoogle Scholar
  185. 176.
    D. Kufe, D. Herrick, C.S. Crumpacker and L. Schnipper, Cancer Res., 44, 69 (1984).PubMedGoogle Scholar
  186. 177.
    G.J. Bubley, C.S. Crumpacker and L. Schnipper, Antimicrob. Agents Chemother., 29, 716 (1986).PubMedGoogle Scholar
  187. 178.
    R. K. Robins, Ann. N.Y. Acad. Sci., 255, 597 (1975) (quote p. 598).PubMedCrossRefGoogle Scholar
  188. 179.
    L.M. Béauchamp, B.L. Dolmach, H.J. Schaeffer, P. Collins, D. J. Bauer, P. M. Keller and J. A. Fyfe, J. Med. Chem., 28, 98a (1985).Google Scholar
  189. 180.
    C.K. Chu and S.J. Cutler, J. Heterocycl. Chem., 23, 289 (1986).CrossRefGoogle Scholar
  190. 181.
    S. Harris and R. K. Robins in “Ribavirin-A Broad Spectrum Antiviral Agent” p. 1, Ed. R.A. Smith and W.A. Kirkpatrick, Academic Press, 1980.Google Scholar
  191. 182.
    T.L. Tsilevich, S.G. Zavgorodny, U. Marx, L.V. Ionova and V.L. Florentiev, Bioorg. Khim., 12, 819 (1986).PubMedGoogle Scholar
  192. 183.
    T. Ito, K. Ohba, M. Koyama, M. Sezaki, H. Tohyama, T. Shomura, H. Fukuyasu, Y. Kazuno, T. Niwa, M. Kojima, T. Niida, J. Antibiot., 37, 931 (1984).PubMedCrossRefGoogle Scholar
  193. 184.
    E.J. Prisbe, J.C Martin, D.P.C McGee, M.F. Barker, D.F. Smee, A.E. Duke, T.R. Matthews, and J.P.H. Verheyden, J. Med. Chem., 29, 671 (1986).PubMedCrossRefGoogle Scholar
  194. 185.
    A.E. Duke, D.F. Smee, M. Chernow, R. Boehme and T.R. Matthews, Antiviral Res., 6, 299 (1986).PubMedCrossRefGoogle Scholar
  195. 186.
    W.C. Koff, R.D. Pratt, J.L. Elm, Jr., C. M. Venkateshan and S. B. Halstead, Antimicrob. Agents Chemother., 24, 134 (1983).PubMedGoogle Scholar
  196. 187.
    J.C. Martin, M.A. Tippie, D.P.C. McGee and J.P.H. Verheyden, J. Pharmaceutical Sci., 76, 180 (1987).CrossRefGoogle Scholar
  197. 188.
    D.S. Freestone, Antiviral Res., 5, 307 (1985).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • Roland K. Robins
    • 1
  • Ganapathi R. Revankar
    • 1
  1. 1.Nucleic Acid Research InstituteCosta MesaUSA

Personalised recommendations